Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer

Background Metastatic head and neck cancers (HNCs) predominantly affect the lungs and have a two‐year overall survival (OS) of 15% to 50%, if amenable for pulmonary metastasectomy. Methods Retrospective review of the two‐year local control (LC), local‐regional control (LRC) within the same lobe, OS,...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Head & neck 2020-08, Vol.42 (8), p.1939-1953
Hauptverfasser:	Pasalic, Dario, Betancourt‐Cuellar, Sonia L., Taku, Nicolette, Ludmir, Ethan B., Lu, Yi, Allen, Pamela K., Tang, Chad, Antonoff, Mara B., Fuller, Clifton D., Rosenthal, David I., Morrison, William H., Phan, Jack, Garden, Adam S., Welsh, James W., Chang, Joe Y., Liao, Zhongxing, Erasmus, Jeremy J., Nguyen, Quynh‐Nhu
Format:	Artikel
Sprache:	eng
Schlagworte:	Head & neck cancer Lung cancer Metastases Metastasis Neck oligometastasis pulmonary metastases pulmonary oligometastases Radiation therapy Squamous cell carcinoma stereotactic body radiotherapy Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!